Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask The Analyst
PDF Library
RSS Feeds
Free Trial Request
Subscribe
Advertising
PR Newswire
UsernamePublicRestriction
Tags:
In Vitro Diagnostics Legislation Regulation

Labs, Test Makers Urge Congress To Pass Diagnostic Reforms

  • News

Executive Summary

More than 80 industry, laboratory, health-care provider and patient groups sent a letter to two congressional committees, urging them to advance a bill to modernize the current way FDA regulates diagnostic tests, including possibly a new regulated product category that combines laboratory developed tests and in vitro diagnostics.

Table

View full table

Advertisement

Related Content

Medtech Insight
FDA Pathway Options Are Growing For Diagnostics, FDA's Gottlieb Tells Commercial Labs
Medtech Insight
Diagnostics Reg Overhaul Floated In US House

Topics

Advertisement
Tags:
In Vitro Diagnostics Legislation Regulation
UsernamePublicRestriction

Register

MT122660

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By